ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
02/16/2024
Back to search
Official data from USPTO
AGEPHA PHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
AGEPHA PHARMA
ST13
US500000079316388Class
3, 5, 44
Filing
79316388
Registration
6810899
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
37
Latest update
02/16/2024
Trademark type
Word
Nice classes
3, 5, 44
Filing date
04/14/2021
Registration date
08/09/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/09/2022
Last transaction
08/09/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
GB
Examiner
NOBLE, ANNIE MELISSA
Law office
L90
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Murray & Poole Enterprises Ltd
A. S. (pessoa física)
Representatives
Jeffrey H. Handelsman Greenblum & Bernstein, P.L.C.
Technical classification
Nice Classes
Class 3Class 5Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 3
Laundry preparationslaundry detergent and laundry bleaching preparations
Class 5
Pharmaceutical products for treating respiratory diseases and asthma; pharmaceutical anti-allergic preparations and substances; pharmaceutical preparations for treating allergic rhinitis and asthma; pharmaceutical products for the treatment and viral and infectious diseasesfor the treatment of cancer; pharmaceutical preparations for the treatment of hormonal disorders at the prevention of osteoporosis; pharmaceutical products and preparations to prevent swelling in the legs; pharmaceutical products and preparations for hydrating the skin during pregnancy; pharmaceutical products and preparations for preventing skin blemishes during pregnancy; pharmaceutical products and preparations to prevent stretch marks; pharmaceutical products for the prevention and treatment of cancer; therapeutic pharmaceutical for the treatment of cardiovascular diseases; pharmaceutical preparations for the treatment of musculo-skeletal disorders; pharmaceutical preparations and substances for the treatment of infectious diseasesblood disorderspaininflammationsepsisalopeciaobesity and cognitive disorders; pharmaceutical preparations and substances for the treatment of damaged skin and tissue; pharmaceutical preparations for skin care; pharmaceutical preparationsappetite suppressants; pharmaceutical preparationsantidepressants; pharmaceutical preparationsa blood clotting aid and delivery system for use in human and veterinary medicine; pharmaceuticalsanti-infectives; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for treating skin disorders; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations for treating allergies; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for the treatment of cardiovascular diseases; pharmaceutical preparations for the peripheral nervous system; pharmaceutical preparations for the treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and/or treatment of hard diseases; pharmaceutical preparations and substances for the treatment of viralmetabolicendocrinemusculo-skeletalcardiovascularcardiopulmonarygenitourinarysexual disfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastro intestinalhormonaldermatologicalpsychiatric and immune system related diseases and disorders; medical preparations for the prevention and treatment of eye diseases; sanitary sterilizing preparations; sanitary preparations for medical purposes; dietary nutritional supplements and dietetic preparations in the nature of food and beverages adapted for medical use; infant formula; nutritional supplements; Plasters for medical purposes; materials for dressingsgauze for dressings; medical dressings; medical plasters; disinfectants soaps and antiseptics; eye drops; eye baths in the nature of saline wash for medical purposes; collyrium; medicated eye-washes; ocular pharmaceuticals; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention of ocular diseases; pharmaceutical preparations for the prevention of ocular disorders; medicinal healthcare preparations for stimulating hair growth; therapeutic medicated bath preparations; tisanes; food supplements for non-medical purposes; disinfectants for medical instruments; dietetic foods adapted for medical purposes; eye bandages for medical use; eye pads for medical use; medicated and sanitising soaps and detergents; dental preparations for disclosing plaque and medicated dentifrices; cardiovascular pharmaceutical preparations; cardiovascular treatment pharmaceuticals
Class 44
Medical services; health care consultancy services; Medical consultancy and medical information services relating to the field of the use of medical products; health counselling; human healthcare serviceswellness programs; human hygiene and beauty care; optometric services
Publications
History of USPTO decisions and trademark events.
37 publications found
CHLD
CHANGE OF OWNER RECEIVED FROM IB
06/09/2023
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
12/12/2022
FICS
FINAL DISPOSITION NOTICE SENT TO IB
11/18/2022
FIMP
FINAL DISPOSITION PROCESSED
11/18/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
11/09/2022
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/09/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
08/09/2022
GPNX
NOTIFICATION PROCESSED BY IB
05/24/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/24/2022
PUBO
PUBLISHED FOR OPPOSITION
05/24/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
05/04/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
05/04/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/04/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/20/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
04/20/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04/20/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
04/20/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/20/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/11/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/10/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/10/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/10/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/10/2022
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
03/10/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/10/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/10/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/10/2022
RFNT
REFUSAL PROCESSED BY IB
01/30/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
01/12/2022
RFRR
REFUSAL PROCESSED BY MPU
01/12/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
12/18/2021
CNRT
NON-FINAL ACTION WRITTEN
12/17/2021
DOCK
ASSIGNED TO EXAMINER
12/07/2021
MAFR
APPLICATION FILING RECEIPT MAILED
08/03/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/30/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/29/2021
Continuous trademark protection
Get notified about every new filing that threatens AGEPHA PHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.